Keywords: T2DM; type 2 diabetes; GLP-1; glucagon-like peptide-1; DPP-IV; dipeptidyl peptidase IV; des-F-sitagliptin; des-fluoro-sitagliptin; PFK; 26-phosphofructo-2-kinase/fructose-2,6-biphosphatase; CF; cytosolic fraction; DNF; nuclear fraction; qPCR; real-time PC
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BMI; body mass index; DM; diabetes mellitus; GCT; glucose challenge test; GDM; gestational diabetes mellitus; IUFD; intrauterine fetal death; LGA; large for gestational age; OGTT; oral glucose tolerance test; PPH; postpartum hemorrhage; T2DM; type 2 diabe
Keywords: Calcium; Ionized calcium; Type 2 diabetes mellitus; Risk; Prospective study; T2DM; type 2 diabetes mellitus; iCa; Ionized calcium; BMI; body mass index; HOMA-IR; homeostasis model assessment-insulin resistance; FPG; fasting plasma glucose; CRP; C-reactive
Keywords: Niacin; Type 2 diabetes; Clinical trial; Meta-analysis; CI; confidence interval; FPG; fasting plasma glucose; HDL-c; HDL cholesterol; LDL-c; LDL cholesterol; RCT; randomised control trial; T2DM; type 2 diabetes mellitus; TG; triglycerides; WMD; weighted m
Keywords: AUC; area under curve; CAT; catalase; DCFH; dichlorofluorescein; DNPH; dinitrophenylhydrazine; GSH; glutathione; GPx; glutathione peroxidase; GR; glutathione reductase; GST; glutathione-S-transferase; GTT; glucose tolerance test; HO-1; heme oxygenase; HOM
Keywords: AGA; appropriate-for-gestational-age; AHEI; alternate healthy eating index; ALT; alanine transaminase; AST; aspartate transaminase; AMPK; 5' adenosine monophosphate-activated protein kinase; aMED; alternate Mediterranean diet score; BMI; body mass index;
Keywords: Fenofibrate; Niacin; Serine; Alanine; T2DM; MetS; Diabetic neuropathy; Serine-Palmitoyltransferase; sphingolipids; 1-deoxysphingolipids;
Keywords: AGRP; Agouti-related peptide; BBB; Blood-brain barrier; CART; Cocaine- and amphetamine-regulated transcript; CAD; Cardiovascular disease; FNDC; Fibronectin type III domain-containing protein; HAART; Highly active antiretroviral therapy; HIV; Human immun
Keywords: Type 2 diabetes mellitus; Quality of care; Chronic disease management; Effectiveness; Retrospective cohort study; ACE; angiotensin converting enzyme; ACHIL; Ambulatory Care Health Information Laboratory; ARB; angiotensin receptor blocker; ATC; anatomical
Keywords: blood glucose; diabetes mellitus; prostate-specific antigen; AER; albumin excretion rate; BMI; body mass index; DCCT; Diabetes Control and Complications Trial; EDIC; Epidemiology of Diabetes Interventions and Complications study; HbA1c; hemoglobin A1c; PC
Keywords: ACCORD; Action to Control Cardiovascular Risk in Diabetes; CI; confidence interval; FBG; fasting blood glucose; HbA1c; glycosylated haemoglobin A1c; HADS-D; Hospital Anxiety and Depression Scale; OR; odds ratio; OADs; oral antidiabetic drugs; PHQ-9; Patie
Keywords: T2DM; HRQL; Treatment; Gender; SF-12;
Keywords: PAHs; Polycyclic aromatic hydrocarbons; CVD; Cardiovascular disease; T2DM; Type 2 diabetes mellitus; PM; Particulate matter; MetS; Metabolic syndrome; OH-PAHs; Monohydroxy urinary metabolites of PAHs; HOMA2; Updated Homeostasis Model Assessment; NHANES; N
Keywords: EPSC; embryonic pluripotent stem cell; IPSC; induced pluripotent stem cell; MODY; maturity-onset diabetes of the young; MPC; multipotent progenitor cell; MSC; mesenchymal stem cell; T1DM; type 1 diabetes mellitus; T2DM; type 2 diabetes mellitus;
Keywords: canagliflozin; composite quality measures; diabetes; quality measures; sitagliptin; T2DM;
Keywords: ASA; acetylsalicylic acid; T2DM; type 2 diabetes mellitus; TX; thromboxane; TP; thromboxane receptor; COX; cyclooxygenase; ROS; reactive oxygen species; AGEs; advanced glycation end products; HO; heme oxygenase; CAD; coronary artery disease; Diabetes mell
Keywords: T2DM; type 2 diabetes mellitus; CHO; carbohydrate; IRB; Institutional Review Board; h; hour; kcal; kilocalorie; kg; kilogram; DPC; Diagnostic Product Corporation; DSL; Diagnostic Systems Laboratories, Incorporated; SDTU; Special Diagnostic & Treatment Uni
Keywords: BMI; body mass index; HbA1c; hemoglobin A1c; mITT; modified intention-to-treat analysis; PN; pen needle; T1DM; type 1 diabetes mellitus; T2DM; type 2 diabetes mellitus; TDD; total daily dose (of insulin);
Keywords: BP; blood pressure; FPG; fasting plasma glucose; GLP-1RA; glucagon-like peptide 1 receptor agonist; HbA1c; hemoglobin A1c; HDL-C; high-density lipoprotein cholesterol; ITT; intent to treat; LDL-C; low-density lipoprotein cholesterol; LS; least-squares; T2
Keywords: Diabetes mellitus; Cancer risk; Insulin; Antidiabetic drugs; ATP; adenosine triphosphate; BMI; body mass index; CI; confidence interval; DDDs; defined daily doses; DNA; deoxyribonucleic acid; DPP-4 inhibitors; dipeptidyl peptidase-4 inhibitors; Egr-1; ear
Keywords: ACLS; Aerobics Center Longitudinal Study; AF; atrial fibrillation; BMI; body mass index; CHD; coronary heart disease; CRF; cardiorespiratory fitness; CVA; cerebrovascular accident; CVD; cardiovascular disease; DLP; dyslipidemia; EET; extreme exercise trai
Keywords: Placenta; Pathology; Histology; Diabetes mellitus; Type 1; Type 2; Gestational; GDM; gestational diabetes mellitus; T1DM; type 1 diabetes mellitus; T2DM; type 2 diabetes mellitus;
Keywords: GV; glycaemic variability; HbA1c; glycosylated hemoglobin; T2DM; type 2 diabetes mellitus; FBG; fasting blood glucose; SMBG; self-monitoring of blood glucose; IDF; International Diabetes Federation; SDBG; standard deviation of blood glucose; LAGE; largest
Keywords: Multiple classifier system; T2DM; Classification
Keywords: CVD; cardiovascular disease; EE; energy expenditure; ME; maternal effects; MRH; maternal resources hypothesis; PA; physical activity; PAEE; physical activity energy expenditure; PE; phenotypic evolution; SEE; socioenvironmental evolution; SM; skeletal mus
Keywords: canagliflozin; ESRD; hepatic impairment; pharmacokinetics; renal impairment; T2DM;
Keywords: ADA; American Diabetes Association; AFABP; adipocyte fatty acid-binding protein; BMI; body mass index; EIA; enzyme immunoassays; GDM; gestational diabetes mellitus; IADPSG; International Association of the Diabetes and Pregnancy Study Groups; IL-6; interl
Keywords: T2DM; type II diabetes mellitus; PI3K; phosphatidyl inositol-3-kinase; (PKC)-ζ; protein kinase C zeta; Akt; protein kinase B; GLUT4; glucose transporter 4; GK/Gyk; glycerol kinase (GK in humans and Gyk in mice); WT; wildtype; KO; knockout; PTP; protein t
Keywords: T2DM; type 2 diabetes mellitus; ESRD; end-stage renal disease; BP; blood pressure; NHANES; National Health and Nutrition Examination Survey; RH; resistant hypertension; GFR; glomerular filtration rate; JSH; Japanese Society for Hypertension; JNC; Joint Na
Keywords: Sirtuins; Diabetic cardiomyopathy; Resveratrol; Acetylation; T1DM; T2DM;
Keywords: AMPK; 5â²-adenosine monophosphate-activated protein kinase; BMI; body mass index; CHB; chronic hepatitis B; CHC; chronic hepatitis C; ChREBP; carbohydrate response element binding protein; Fox; forkhead box protein; HCC; hepatocellular carcinoma; HSCs;
Keywords: Insulin resistance; Overfeeding, Serum testosterone; Steroidogenic enzymes; T2DM; Type 2 diabetes mellitus; FH; Family History; DHEA; Dehydroepiandrosterone; DHEA-S; Dehydroepiandrosterone and its sulfate derivate; DHT; 5α-Dihydrotestosterone; 3β-HSD; 3
Keywords: CI; Confidence interval; DF; Diabetic foot; DFP-CoDe; Diabetic Foot Patients-Cognition and Depression; IWGDF; International Working Group on Diabetic Foot; MMSE; Mini-Mental State Examination; TMT-A; Trial Making Test part A; TMT-B; Trial Making Tes
Keywords: AFABP; adipocyte fatty acid-binding protein; BMI; body mass-index; CRP; C reactive protein; ELISA; enzyme-linked immunosorbent assay; FFA; free fatty acids; FG; fasting glucose; FGF-21; fibroblast growth factor-21; FI; fasting insulin; GDM; gestational di
Keywords: AUC; area under curve; BF%; body fat percentage; BMI; body mass index; CI; confidence interval; CVD; cardiovascular disease; DBP; diastolic blood pressure; FPG; fasting plasma glucose; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipopr
Keywords: Glycated hemoglobin (HbA1c); Body weight; Postprandial plasma glucose (PPG); AE; adverse event; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; FPG; fasting plasma glucose; GI; gastrointestinal; GLP-1; glucagon-like peptide-1; HbA1c; glycated hemoglo
Keywords: BS; bariatric surgery; T2DM; type 2 diabetes; EGP; endogenous glucose production; HGU; hepatic glucose uptake; VLCD; very-low-calorie diet; PET; positron emission tomography; 18F-FDG; 18F-fluorodeoxyglucose; MRI; magnetic resonance imaging; SG; sleeve gas
Keywords: diabetes mellitus; methotrexate; National Health Insurance Research Database; psoriasis; severity; thiazide; CI; confidence interval; DDDs; defined daily doses; DM; diabetes mellitus; HR; hazard ratio; ICD-9; International Classification of Diseases, Nint
Keywords: T2DM; type 2 diabetes mellitus; CM; conditioned medium; ATM; adipose tissue macrophage; TNFα; tumor necrosis factor alpha; LPS; lipopolysaccharide; IFNγ; interferon gamma; iNOS; inducible nitric oxide synthase; COX-2; cyclooxygenase-2; MCP-1; monocyte c
Keywords: T2DM; Cardiovascular complications; Imaging biomarkers
Keywords: T2DM; Type 2 Diabetes Mellitus; HbA1c; Glycated Hemoglobin; BMD; Bone Mineral Density; BMI; Body Mass Index; pQCT; peripheral Quantitative Computed Tomography; DXA; Dual-Energy X-ray Absorptiometry; TBS; Trabecular Bone Score; BMS; Bone Material Strength;
Keywords: T2DM; type 2 diabetes mellitus; IGR; impaired glucose regulation; IGT; impaired glucose tolerance; IFG; impaired fasting glucose; AUROC; area under the receiver operator curve; ADA; American Diabetes Association; EPV; events per variable; Type 2 diabetes;
Keywords: aDMR; age-associated differentially methylation regions; DNMTs; DNA methyltransferases; ROS; reactive oxygen species; CR; caloric restriction; DR; dietary restriction; ADF; alternate-day fasting; PBMCs; peripheral blood mononuclear cells; AdoMet; S-adenos
Keywords: ACAT; acyl-CoA cholesterol acyltransferase; ACC; acetyl CoA carboxylases; ACLY; ATP citrate lyases; ACSL; acyl CoA synthetases long chain family; ADRP; adipose differentiation related protein; AGP; advanced glycation end products; AGPAT; acylglycerophosph
Keywords: AGA; appropriate for gestational age; GDM; gestational diabetes mellitus; LGA; large for gestational age; T2DM; type 2 diabetes mellitus; NUCB2; nucleobindin 2; Adipokines; Fetus; Insulin resistance; Neonate; Nesfatin-1;
Keywords: GWAS; genome-wide association study; LD; linkage disequilibrium; MAF; minor allele frequency; SNP; single nucleotide polymorphism; T2DM; type 2 diabetes; Diabetes; Genome wide association; Replication; TCF7L2;
Keywords: AGEs; advanced glycation end-products; VEGF; vascular endothelial growth factor; T2DM; type 2 diabetes mellitus; MTT; [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; PDB; phorbol dibutyrate; PKC; protein kinase C; DG; diacylglycerol; Aqueou
Keywords: T1DM; type 1 diabetes; LV; left ventricular; MRI; magnetic resonance imaging; LA; left atrial; HC; healthy controls; T2DM; type 2 diabetes; CAD; coronary artery disease; DecT; deceleration time; EF; ejection fraction; EDV; end-diastolic volume; ESV; end-s
Keywords: BMI; body mass index; CAPN10; Calpain-10 gene; cDNA; complementary DNA; CT; threshold cycle; ÎCT; CT (target gene) â CT (endogenous reference gene); ÎÎCT; average CT (sample of interest) â average CT (reference sample); CVs; coefficients of var
Keywords: Glucokinase; Glucokinase activator; GKAs; YH-GKA; T2DM; Type 2 diabetes mellitus; OGTT;